Immunotherapy has been a game-changer for treating cancers such as melanoma, lung cancer and bladder cancer. Now, the U.S. Food and Drug Administration (FDA) has approved the first-ever combination of an immunotherapy drug (atezolizumab), plus chemotherapy (nabpaclitaxel) for treating breast cancer. Jame Abraham, M.D., an oncologist at Cleveland Clinic, one of the United States’ leading cancerRead more about First Immunotherapy Treatment for Breast Cancer Approved in the United States[...]
Read More